期刊文献+

人肝内胆管癌细胞株RBE的基因表达 被引量:2

Gene expressions of the human intrahepatic cholangiocarcinoma RBE cell line
原文传递
导出
摘要 目的 通过比较肝内胆管细胞癌RBE细胞株中NCAM+ c-Kit+与NCAM-c-Kit-的全基因组表达差异,筛选出与干细胞信号通路相关的差异基因,进一步揭示肝内胆管癌发生、发展的内在分子机制.方法 培养RBE细胞株,用免疫磁珠分选出NCAM+ c-Kit+ RBE与NCAM-c-Kit-RBE亚群,采用Agilent人全基因组表达谱芯片对NCAM+ c-Kit+ RBE与NCAM-c-Kit-RBE进行检测.通过SAS系统分析,得到两者干细胞信号通路的差异表达基因,进一步采用实时-PCR技术验证芯片结果.结果 芯片筛选出NCAM+ c-Kit+ RBE与NCAM-c-Kit-RBE亚群之间的差异基因共7270条[变化倍数(fc)≥2或fc≤0.5].与NCAM-c-Kit-RBE相比,NCAM+ c-Kit+ RBE上调基因3572条,下调基因3698条.其中干细胞信号通路相关差异基因共421条(fc≥2或fc≤0.5),上调基因231条,下调基因190条.结论 高通量芯片能够筛选出NCAM+ c-Kit+ RBE与NCAM-c-Kit-RBE大量的差异基因.SAS分析系统能进一步分析与干细胞信号通路相关的差异基因. Objective To analyze the differentially expressed genes between the NCAM + c-Kit +RBE and NCAM-c-Kit-RBE of intrahepatic cholangiocarcinoma (ICC) cell lines,and to screen out the differentially expressed genes that are related to the stem cell signaling pathways.Methods Magnetic activated cell sorting was used to isolate the NCAM + c-Kit +/NCAM-c-Kit-subset cells,and then Agilent Whole Human Genome Microarray Kit was used to test the difference in gene expressions between the NCAM + cKit + and NCAM-c-Kit-subset cells.The difference in gene expressions related to the stem cell signaling pathways was analyzed by the SAS system.The result of the microarray was further confirmed by RT-PCR.Results The total differentially expressed genes which could be found through gene microarray were 7270 [foldchange(fc) ≥2 or fc ≤0.5].Compared with the NCAM-c-Kit-RBE,3572 genes were upregulated while 3698 genes were downregulated.The differences in gene expressions related to the stem cell signaling pathways were 421 (fc ≥2 or fc ≤ 0.5),among which 231 genes were upregulated while 190 genes were downregulated.Conclusions High-flux microarray could be used to screen out lots of differentially expressed genes between the NCAM + c-Kit + and NCAM-c-Kit-RBE cells.The differences in gene expression in the stem cell signaling pathways could also be further analyzed using the SAS system.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2015年第6期373-376,共4页 Chinese Journal of Hepatobiliary Surgery
基金 山西省回国留学人员科研项目(2011-046) 山西省留学回国人员科技活动择优资助项目资助(2011-762) 山西医科大学基础医学院331基础医学科技培植基金计划项目(201407) 山西医科大学校创新基金(01201302)
关键词 肝内胆管癌 肝脏干/祖细胞 基因芯片 信号通路 Intrahepatic cholangiocarcinoma Hepatic stem/progenitor cell Gene microarray Signaling pathway
  • 相关文献

参考文献4

二级参考文献61

  • 1苗丽君,王静.Akt与肿瘤的研究进展[J].国外医学(生理病理科学与临床分册),2004,24(5):406-409. 被引量:38
  • 2Toshifumi Wakai,Yoshio Shirai,Katsuyoshi Hatakeyama.Peroral cholangioscopy for non-invasive papillary cholangio-carcinoma with extensive superficial ductal spread[J].World Journal of Gastroenterology,2005,11(41):6554-6556. 被引量:3
  • 3Shaib YH, E1-Serag HB, Davila JA, et al. Risk factors of in- trahepatic cholangiocarcinoma in the United States a case- control study[J]. Gastroenterology, 2005,128 : 620-626.
  • 4Shaib YH, Davila JA, Mcglynn K, ct al. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? [J]. J Hepatol,2004,40:472-477.
  • 5Khan SA, Thomas HC, Davidson BR, et al. Cholangiocarci- noma[J]. Lancet, 2005,366 :1303-1314.
  • 6Poultsides GA, Zhu AX, Choti MA, et al. Intrahepatic cholangio- careinoma[J]. Surg Clin North Am, 2010,90:817-837.
  • 7Ryan BM, Robles AI, Harris CC. Genetic variation in mi- croRNA networks: the imp[ications for cancer researeh[J]. Nat Rev Cancer, 2010,10:389-402.
  • 8Gentilin E, Tagliati F, Filieri C, et al. miR-26a plays an im- portant role in cell cycle regulation in ACTH-secreting pituita- ry adenomas by modulating protein kinase Cdelta [J ]. Endocrinology, 2013,154 : 1690-1700.
  • 9Yu L, Lu J, Zhang B, et al. miR-26a inhibits invasion and me- tastasis of nasopharyngea! cancer by targeting EZH2 [J]. Oncol Lett, 2013,5 : 1223-1228.
  • 10Gao J, Li L, Wu M, et al. MiR-26a Inhibits proliferation and migration of breast cancer through repression of MCL-I[J].PLoS One, 2013,8:e65138.

共引文献13

同被引文献28

  • 1方瑞,郭强,杜军.高表达Snail蛋白诱导黑色素瘤EMT细胞模型的构建及鉴定[J].中国生物工程杂志,2013,33(7):1-7. 被引量:3
  • 2徐菁.原发性肝癌的肝脏祖细胞特性研究[D].北京:军事医学科学出版社,2015.
  • 3Oishi N, Wang XW. Novel therapeutic strategies for targe- ting liver cancer stem cells[J]. Int J Biol Sci, 2011, 7 (5) :517-535.
  • 4Infante P, Alfonsi R, Botta B, et al. Targeting GLI factors to inhibit the Hedgehog pathway [ J ]. Trends Pharmacol Sci, 2015, 36(8) :547-548.
  • 5Xie JW, Bartels CM, Barton SW, et al. Targeting hedge- hog signaling in cancer: research and clinical develop- ments[J]. Onco Targets Ther, 2013, 6:1425-1435.
  • 6Lee ST, Welch KD, Panter Ke, et al. Cyclopamine: from cyclops iambs to cancer treatment[J]. J Agr Food Chem, 2014, 62 (30) :7355-7362.
  • 7Berman DM, Karhadka SS, Hallahan AR, et al. Medullo- blastoma growth inhibition by hedgehog pathway blokade [J]. Science, 2002, 297(5586): 1559-1561.
  • 8Cohen MM Jr. The hedgehog signaling network[J]. Am J Med Genet A, 2003, 123A(1) :5-28.
  • 9Thayer SP, Di Magliano MP, Heiser PW, et al. Hedgehog is an early and late mediator of pancreatic cancer tumori- genesis[J]. Nature, 2003, 425(6960): 851-856.
  • 10Berman DM, Karhadkar SS, Maitra A. Widespread require- ment for Hedgehog ligand stimulation in growth of digestive tract tumour[ J ]. Nature, 2003, 425(6960) : 846-851.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部